Index Catalog // STAX

Cancellare i filtri

Filtro per: Collaboratore GlaxoSmithKline Dipartimento, Scuola o Facoltà Strathclyde Institute of Pharmacy and Biomedical Sciences Tipo di risorsa http://purl.org/coar/resource_type/c_db06

Investigating streptomyces clavuligerus linear replicons for improved clavulanic acid production

Creatore:

Mohit, Elmira

Data:

2023 and 2024

Funder:

Biotechnology and Biological Sciences Research Council, GlaxoSmithKline, and Industrial Biotechnology Innovation Centre

Department, School or Faculty:

Strathclyde Institute of Pharmacy and Biomedical Sciences
Early application of mechanistic PKPD modelling to guide the preclinical development of a therapeutic mAb targeting complement receptor 2 (CR2/CD21) as a novel target for the treatment of autoimmune disease

Creatore:

Hooper-Greenhill, Edward

Data:

2021

Funder:

GlaxoSmithKline

Department, School or Faculty:

Strathclyde Institute of Pharmacy and Biomedical Sciences
Pharmacological characterisation of small molecule RGD-mimetics targeting αvβ6-mediated activation of TGFβ in idiopathic pulmonary fibrosis

Creatore:

Slack, Robert J.

Data:

2015

Funder:

GlaxoSmithKline

Department, School or Faculty:

Strathclyde Institute of Pharmacy and Biomedical Sciences
New dose estimation methods and their application in early drug discovery using intravenous, oral and inhaled routes of administration for new chemical entities

Creatore:

Teague, Simon Peter

Data:

2019

Funder:

GlaxoSmithKline

Department, School or Faculty:

Strathclyde Institute of Pharmacy and Biomedical Sciences
Development towards prospective modelling of in vivo rabbit QTc prolongation

Creatore:

Lewis, Gareth John

Data:

2017

Funder:

GlaxoSmithKline

Department, School or Faculty:

Strathclyde Institute of Pharmacy and Biomedical Sciences

Investigating streptomyces clavuligerus linear replicons for improved clavulanic acid production

Early application of mechanistic PKPD modelling to guide the preclinical development of a therapeutic mAb targeting complement receptor 2 (CR2/CD21) as a novel target for the treatment of autoimmune disease

Pharmacological characterisation of small molecule RGD-mimetics targeting αvβ6-mediated activation of TGFβ in idiopathic pulmonary fibrosis

New dose estimation methods and their application in early drug discovery using intravenous, oral and inhaled routes of administration for new chemical entities

Development towards prospective modelling of in vivo rabbit QTc prolongation

Affina la ricerca

genere

Tipo di risorsa

Creatore

Collaboratore

Funder

Dipartimento, Scuola o Facoltà

Data

Ricerca

Risultati della ricerca

Affina la ricerca